Reliv International Reports Second-Quarter Financial Results

Reliv International Reports Second-Quarter Financial Results

CHESTERFIELD, Mo., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Reliv International, Inc.
(Nasdaq:RELV), a maker of nutritional supplements that promote optimal health,
today reported its financial results for the second quarter of 2013.

Net sales for the quarter were $15.4 million, an 8.1 percent decrease from the
second quarter last year. Net U.S. sales totaled $11.8 million, down from
second-quarter 2012 net sales of $12.9 million. Net sales outside of the
United States declined 6.3 percent in the second quarter of 2013 compared to
the prior-year quarter as net sales declined by 46.5 percent in Asia, offset
by sales increases of 12.6 percent in Europe and 9.2 percent in Australia/New
Zealand.

The net loss for the second quarter of 2013 was ($214,000) or ($0.02) per
diluted share, compared to net income of $103,000 or $0.01 per diluted share
in the 2012 second quarter.

Net sales in Europe increased to $1.96 million in the second quarter of 2013
compared to $1.74 in the prior-year second quarter. "Europe continues to lead
all overseas areas in growth as Reliv added France as our 16^th market in
May," said Robert L. Montgomery, chairman and chief executive officer of
Reliv. "We anticipate continued growth and are investing in our leadership and
resources in Europe."

Australia/New Zealand increased net sales to $524,000 in the second quarter of
2013 compared to $480,000 in the same quarter in 2012. "We introduced a new
pricing structure and a preferred customer program in this region in an effort
to spur growth," Montgomery said. "We implemented similar initiatives in Asia,
including new leadership in senior management positions, and I believe these
initiatives will lead to a positive turnaround in these markets as well."

Overall, the reduction in profitability is due to the decline in worldwide
sales. Selling, general and administrative expenses increased in 2013 due to a
long-term performance-based compensation agreement with Reliv's European
managers that began accruing in the fourth quarter of 2012. Reliv recorded
expense of $156,000 in the current quarter and $201,000 for the year-to-date
related to the agreement. In addition, unfavorable foreign currency exchange
rate fluctuations totaled $68,000 in the quarter due to a strengthening U.S.
dollar.

In July 2013, Reliv entered into a license agreement with Soy Labs, LLC to
secure exclusive rights to certain intellectual property related to lunasin, a
dietary ingredient that promotes optimal health at the epigenetic level. The
license covers an issued patent and several patent applications related to
lunasin and soy-related peptides, proprietary information, and manufacturing
processes of Soy Labs, LLC.

"Part of our long-term sales and marketing strategy worldwide is to position
Reliv to benefit from the growing popularity of epigenetics," Montgomery said.
"The science of epigenetics is now hitting mainstream media and we believe
nutritional epigenetics will soon follow. Our license of the intellectual
property related to the commercialization of lunasin positions Reliv as
industry leader in this emerging field of study."

"Our LunaRich product line, which optimizes lunasin levels, has energized our
distributor force and shown significant potential for sales growth," he added.
"Reliv Now® with LunaRich has become our top seller, comprising 18.4 percent
of net sales in the United States in the second quarter 2013, while LunaRich
X™, launched in January 2013, accounted for 8.5 percent of second quarter 2013
net sales in the United States. For the first time Reliv now controls an
ingredient in its entirety, from the proprietary extraction process to the
patented mechanisms of action within the body. I believe this places Reliv in
a unique position in the industry and provides an opportunity for growth."

Net sales for the first six months of 2013 were $34.3 million, which
represents a 6.1 percent decrease from the same period in 2012. Reliv's
international net sales declined 6.0 percent in the first half of 2013
compared with the first half of last year. In the United States, net sales
declined 6.2 percent. Reliv reported a net loss of ($19,000), or ($0.00) per
diluted share in the first six months of 2013, compared to net income of
$635,000 or $0.05 per diluted share in the same period of 2012.

Reliv's total distributor count was 53,390 as of June 30, 2013 – a decrease of
9.9 percent from the same date in 2012 – of which 5,910 are Master Affiliate
level and above. The number of Master Affiliates decreased by 7.9 percent
compared to the year ago total. Master Affiliate is the level at which
distributors are eligible to earn generation royalties.

Reliv had cash and cash equivalents of $4.26 million as of June 30, 2013, a
decrease of $1.25 million over the same date last year.

About Reliv International, Inc.

Reliv International, Inc., based in Chesterfield, MO, produces nutritional
supplements that promote optimal nutrition along with premium skincare
products. Reliv supplements address essential nutrition, weight loss, athletic
performance, digestive health, women's health, anti-aging and healthy energy.
Reliv is the exclusive provider of LunaRich® products, which optimize levels
of lunasin, the peptide behind many of soy's health benefits. The company
sells its products through an international network marketing system of
independent distributors in 16 countries. Learn more about Reliv at
www.reliv.com, or on Facebook, Twitter or YouTube.

Statements made in this news release that are not historical facts are
"forward-looking" statements (as defined in the Private Securities Litigation
Reform Act of 1995) that involve risks and uncertainties and are subject to
change at any time. These forward-looking statements may include, but are not
limited to, statements containing words such as "may," "should," "could,"
"would," "expect," "plan," "anticipate," "believe," "estimate," "predict,"
"potential," "continue" or similar expressions. Factors that could cause
actual results to differ are identified in the public filings made by Reliv
with the Securities and Exchange Commission. More information on factors that
could affect Reliv's business and financial results are included in its public
filings made with the Securities and Exchange Commission, including its Annual
Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are
available on the Company's web site, www.reliv.com.

                       – FINANCIAL HIGHLIGHTS FOLLOW –

                                                              
Reliv International, Inc. and Subsidiaries
ADD TWO
                                                              
Condensed Consolidated                                         
Balance Sheets
                        June 30       December 31               
                        2013          2012                      
                        (Unaudited)                            
Assets                                                         
Current Assets:                                                
Cash and cash            $4,255,963    $5,801,042                
equivalents
Accounts receivable,
less allowances of       172,899       247,087                   
$32,000 in 2013 and
$35,700 in 2012
Accounts and notes due
from employees and       141,372       109,346                   
distributors
Inventories              5,582,010     5,262,916                 
Other current assets     1,770,872     1,070,301                 
                                                              
Total current assets     11,923,116    12,490,692                
                                                              
Other assets             4,450,630     4,212,442                 
Intangible assets, net   1,366,630     1,443,635                 
Net property, plant and  6,875,143     7,111,772                 
equipment
                                                              
Total Assets             $24,615,519   $25,258,541               
                                                              
Liabilities and                                                
Stockholders' Equity
                                                              
Total current            $6,363,528    $6,614,631                
liabilities
Long-term debt, less     2,194,129     2,401,312                 
current maturities
Other non-current        796,162       660,728                   
liabilities
Stockholders' equity     15,261,700    15,581,870                
                                                              
Total Liabilities and    $24,615,519   $25,258,541               
Stockholders' Equity
                                                              
                                                              
Consolidated Statements                             
of Operations
                        Three months ended June 30 Six months ended June 30
                        2013          2012          2013         2012
                        (Unaudited)   (Unaudited)   (Unaudited)  (Unaudited)
Product sales            $14,165,463   $14,894,640   $31,054,921  $32,509,480
Handling & freight       1,259,945     1,886,064     3,227,751    4,014,868
income
                                                              
Net Sales                15,425,408    16,780,704    34,282,672   36,524,348
                                                              
Costs and expenses:                                            
Cost of products sold   3,057,940     3,220,860     6,961,798    7,121,441
Distributor royalties   5,617,245     6,319,613     12,620,448   13,774,773
and commissions
Selling, general and    6,972,599     7,021,658     14,488,088   14,495,904
administrative
                                                              
Total Costs and Expenses 15,647,784    16,562,131    34,070,334   35,392,118
                                                              
Income (loss) from       (222,376)     218,573       212,338      1,132,230
operations
                                                              
Other income (expense):                                        
Interest income          38,668        40,863        75,832       50,177
Interest expense         (18,493)      (31,295)      (35,995)     (62,214)
Other income (expense)   (64,544)      (38,564)      (91,119)     (61,232)
                                                              
Income (loss) before     (266,745)     189,577       161,056      1,058,961
income taxes
Provision (benefit) for  (53,000)      87,000        180,000      424,000
income taxes
                                                              
Net Income (loss)        ($213,745)    $102,577      ($18,944)    $634,961
                                                              
                                                              
Earnings (loss) per      ($0.02)       $0.01         ($0.00)      $0.05
common share - Basic
Weighted average shares 12,616,000    12,507,000    12,617,000   12,499,000
                                                              
Earnings (loss) per      ($0.02)       $0.01         ($0.00)      $0.05
common share - Diluted
Weighted average shares 12,708,000    12,678,000    12,707,000   12,658,000
                                                              
Cash dividends declared  $0.02         $0.02         $0.02        $0.02
per common share

                                                                       
Reliv International, Inc. and Subsidiaries
ADD THREE
                                                                       
Net sales by Market
(in thousands)
             Three months ended June 30,                       Change From
             2013                     2012                     Prior Year
             Amount        % of Net   Amount        % of Net   Amount       %
                            Sales                    Sales
                                                                       
United States $11,828     76.7%      $12,943     77.1%      $(1,115)   -8.6%
Australia/New 524          3.4%       480          2.9%       44          9.2%
Zealand
Canada        372          2.4%       439          2.6%       (67)        -15.3%
Mexico        256          1.7%       271          1.6%       (15)        -5.5%
Europe        1,960        12.7%      1,741        10.4%      219         12.6%
Asia          485          3.1%       907          5.4%       (422)       -46.5%
                                                                       
Consolidated  $15,425     100.0%     $16,781     100.0%     $(1,356)   -8.1%
total
                                                                       
                                                                       
Net sales by Market
(in thousands)
             Six months ended June 30,                         Change From
             2013                     2012                     Prior Year
             Amount        % of Net   Amount        % of Net   Amount       %
                            Sales                    Sales
                                                                       
United States $26,938     78.6%      $28,713     78.6%      $(1,775)   -6.2%
Australia/New 973          2.8%       1,020        2.8%       (47)        -4.6%
Zealand
Canada        926          2.7%       989          2.7%       (63)        -6.4%
Mexico        534          1.6%       558          1.6%       (24)        -4.3%
Europe        3,979        11.6%      3,335        9.1%       644         19.3%
Asia          933          2.7%       1,909        5.2%       (976)       -51.1%
                                                                       
Consolidated  $34,283     100.0%     $36,524     100.0%     $(2,241)   -6.1%
total
                                                                       
The following table sets forth, as of June 30, 2013 and 2012, the number of our active
distributors and Master Affiliates and above. The total number of active distributors
includes Master Affiliates and above.We define an active distributor as one that
enrolls as a distributor or renews its distributorship during the prior twelve
months.Master Affiliates and above are distributors that have attained the highest
level of discount and are eligible for royalties generated by Master Affiliates and
above in their downline organization.
                                                                       
Active Distributors and Master Affiliates and above by Market
                                                                       
             As of 6/30/2013          As of 6/30/2012          Change in %
              TotalActive Master     TotalActive Master     TotalActive Master
             Distributors  Affiliates Distributors  Affiliates Distributors Affiliates
                            and Above                and Above               and Above

                                                                       
United States 38,860        4,180      42,080        4,790      -7.7%        -12.7%
Australia/New 1,570         200        1,940         130        -19.1%       53.8%
Zealand
Canada        1,260         180        1,320         200        -4.5%        -10.0%
Mexico        1,150         130        1,800         150        -36.1%       -13.3%
Europe        6,490         780        6,020         600        7.8%         30.0%
Asia          4,060         440        6,070         550        -33.1%       -20.0%
                                                                       
Consolidated  53,390        5,910      59,230        6,420      -9.9%        -7.9%
total

CONTACT: Steve Albright
         Chief Financial Officer
         (636) 733-1305